Three Japanese Cos. Recall Heparin Products

Law360, New York (March 11, 2008, 12:00 AM EDT) -- Three Japanese drugmakers have begun a voluntary recall of 17 heparin sodium products as a “precautionary step,” after the blood thinner caused allergic reactions and 21 deaths in the United States.

Wisconsin-based Scientific Protein Laboratories Inc., which sourced heparin's main ingredient in China for the Japanese companies, said on Monday that there had been no adverse events reported in Japan related to the drug.

“The three Japanese companies made clear that the recall was simply a precaution, as there has not been a pattern of adverse...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.